Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ: VRTX · Real-Time Price · USD

459.62

+2.59 (0.57%)

At close: Jul 3, 2025, 1:00 PM

459.00

-0.62 (-0.13%)

After-hours: Jul 3, 2025, 2:29 PM EDT

Vertex Pharmaceuticals Market Cap

Vertex Pharmaceuticals has a market cap or net worth of $118.03 billion as of July 3, 2025. Its market cap has decreased by -3.44% in one year.

Market Cap

118.03B

Enterprise Value

108.32B

1-Year Change

-3.44%

Ranking

#122

Market Cap Chart

Since December 1, 1998, Vertex Pharmaceuticals's market cap has increased from $611.50M to $118.03B, an increase of 19,201.57%. That is a compound annual growth rate of 21.87%.

Market Cap History

Date	Market Cap	% Change
Jul 3, 2025	118.03B	13.81%
Dec 31, 2024	103.71B	-1.09%
Dec 29, 2023	104.85B	41.44%
Dec 30, 2022	74.13B	32.76%
Dec 31, 2021	55.83B	-9.15%
Dec 31, 2020	61.46B	9.15%
Dec 31, 2019	56.30B	32.95%
Dec 31, 2018	42.35B	11.74%
Dec 29, 2017	37.90B	107.41%
Dec 30, 2016	18.27B	-40.90%
Dec 31, 2015	30.92B	8.21%
Dec 31, 2014	28.57B	64.52%
Dec 31, 2013	17.37B	91.17%
Dec 31, 2012	9.09B	31.16%
Dec 30, 2011	6.93B	-2.69%
Dec 31, 2010	7.12B	-8.32%
Dec 31, 2009	7.76B	69.85%
Dec 31, 2008	4.57B	48.74%
Dec 31, 2007	3.07B	-34.61%
Dec 29, 2006	4.70B	71.34%
Dec 30, 2005	2.74B	223.10%
Dec 31, 2004	848.90M	5.56%
Dec 31, 2003	804.20M	-33.56%
Dec 31, 2002	1.21B	-34.33%
Dec 31, 2001	1.84B	-56.32%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	700.84B
Johnson & Johnson	375.37B
AbbVie	334.34B
Novo Nordisk	316.33B
UnitedHealth Group	279.90B
Novartis AG	242.35B
Abbott Laboratories	233.90B
AstraZeneca	218.65B

Market Cap Rankings